Macrogen Europe

Macrogen Europe B.V. is a leading biotechnology service provider specializing in high-quality genomic sequencing and bioinformatics. Founded in 2008 as a branch and incorporated as a subsidiary in 2017, the company serves as the European hub for its South Korean parent, Macrogen Inc. It provides a comprehensive suite of services including Next-Generation Sequencing (NGS), Sanger sequencing, fragment analysis, and oligonucleotide synthesis to academic, clinical, and pharmaceutical researchers. The company operates state-of-the-art laboratory facilities in Amsterdam and has recently expanded its physical presence with a new facility in Basel, Switzerland. Macrogen Europe is known for its rapid turnaround times and competitive pricing, leveraging the latest technology from partners like Illumina, Pacific Biosciences, and Oxford Nanopore. It is increasingly focusing on AI-driven precision medicine and clinical diagnostics to support the transition toward personalized healthcare.